Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Zoe Kordatou"'
Autor:
Marc Abraham, Zoe Kordatou, Jorge Barriuso, Angela Lamarca, Jamie M J Weaver, Claudia Cipriano, George Papaxoinis, Alison Backen, Wasat Mansoor
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224540 (2019)
Cancer cachexia is common in patients with oesophagogastric cancer (OG) and is linked to overall survival (OS). One of the key components of cachexia is anorexia; it is not known whether anorexia impacts on OS and there is no method of routine screen
Externí odkaz:
https://doaj.org/article/3a70179684cf4679b883be202b35974f
Autor:
George Papaxoinis, Wasat Mansoor, Vikki Owen-Holt, Simon Galloway, Jamie Mj. Weaver, Ana Patrao, Bilal Alkhaffaf, Zoe Kordatou
Publikováno v:
European Journal of Surgical Oncology. 45:439-445
Background The aim of the present study was to assess the prognosis of patients with esophageal or gastroesophageal junction (E/GEJ) adenocarcinoma extending beyond the muscularis propria layer (≥ypT3) and positive circumferential resection margin
Autor:
Sofia Stamatopoulou, Magdy Nasralla, Vikki Owen-Holt, George Papaxoinis, Alan Anthoney, Theodora Germetaki, Zoe Kordatou, Wasat Mansoor, Jamie M J Weaver, Konstantinos Kamposioras
Publikováno v:
Journal of Gastrointestinal Surgery. 23:1729-1741
The aim of this cohort study was to assess the benefit that patients with lower esophageal or gastroesophageal junction (E/GEJ) adenocarcinoma receive by continuing perioperative chemotherapy post-surgery. Three hundred twelve patients underwent radi
Autor:
Leila Khoja, Theodora Germetaki, Ana Patrao, Zoe Kordatou, Alia Alchawaf, George Papaxoinis, Sofia Stamatopoulou, Jamie M J Weaver, Vikki Owen-Holt, Wasat Mansoor
Publikováno v:
Acta Oncologica. 56:1224-1232
The new American Joint Committee on Cancer eighth edition (AJCC8) staging is the first to describe separate clinical and pathology staging systems, but still has low performance to predict prognosis in patients with oesophageal/gastroesophageal junct
Autor:
Jorge Barriuso, Claudia Cipriano, Zoe Kordatou, George Papaxoinis, Marc Abraham, Wasat Mansoor, Alison Backen, Angela Lamarca, Jamie M J Weaver
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224540 (2019)
PLoS ONE
PLoS ONE
Cancer cachexia is common in patients with oesophagogastric cancer (OG) and is linked to overall survival (OS). One of the key components of cachexia is anorexia; it is not known whether anorexia impacts on OS and there is no method of routine screen
Autor:
Prakash Manoharan, Juan W. Valle, Jorge Barriuso, Mairéad G McNamara, Christina Nuttall, Melissa Frizziero, Francesca Spada, Richard A Hubner, Zoe Kordatou, Wasat Mansoor, Angela Lamarca, Nicola Fazio
Publikováno v:
Frizziero, M, Spadaro, F, Lamarca, A, Kordatou, Z, Barriuso, J, Nuttall, C, Mcnamara, M, Hubner, R, Mansoor, W, Manoharan, P, Fazio, N & Valle, J 2019, ' Carboplatin in combination with oral or intravenous etoposide for extra-pulmonary, poorly-differentiated neuroendocrine carcinomas ', Neuroendocrinology . https://doi.org/10.1159/000497336
Background: Carboplatin-etoposide (CarboEtop) is a 1st-line option for patients with advanced extra-pulmonary (EP), poorly-differentiated (PD) neuroendocrine carcinoma (NEC). Different schedules are used in clinical practice and randomised evidence i
Autor:
George Papaxoinis, Vikki Owen-Holt, Zoe Kordatou, Jamie M J Weaver, Konstantinos Kamposioras, Magdy Nasralla, Theodora Germetaki, Alan Anthoney, Wasat Mansoor, Sofia Stamatopoulou
Publikováno v:
Acta oncologica (Stockholm, Sweden). 57(6)
Thromboembolic events (TEEs) represent a significant treatment and disease complication for cancer patients. In the present study we assessed the incidence of TEEs in patients receiving preoperative chemotherapy for esophagogastric adenocarcinoma. Th
Autor:
Angela Lamarca, Christina Nuttall, Jorge Barriuso, Richard A Hubner, Prakash Manoharan, Melissa Frizziero, Juan W. Valle, Zoe Kordatou, Mairéad G McNamara, Wasat Mansoor
Publikováno v:
Frizziero, M, Lamarca, A, Kordatou, Z, Barriuso, J, Nuttall, C, Mcnamara, M, Hubner, R A, Mansoor, W, Manoharan, P & Valle, J 2017, ' Carboplatin-etoposide chemotherapy for patients with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC); outcomes from a European Neuroendocrine Tumour Society Centre of Excellence ', UKI NETS 2017, 4/12/17 pp. 21 . https://doi.org/10.1530/endoabs.52.P21
Introduction: Platinum-etoposide is considered standard-of-care first-line treatment for patients diagnosed with advanced EP-PD-NECs. The optimal platinum-etoposide schedule remains undefined; carboplatin is often substituted for cisplatin, although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40c378017e5774beba5ae88ff955a30b
https://doi.org/10.1530/endoabs.52.P21
https://doi.org/10.1530/endoabs.52.P21
Autor:
Zoe Kordatou, Daisuke Nonaka, Magdy Nasralla, Lynn McCallum, Wasat Mansoor, Zena Salih, George Papaxoinis
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.